UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019332
Receipt No. R000022159
Official scientific title of the study Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period
Date of disclosure of the study information 2015/10/13
Last modified on 2016/06/27 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Volume expanding effect and peripheral perfusion of 130 HES in the patients during perioperative period
Title of the study (Brief title) Efficacy of 130 HES in the patients during perioperative period
Region
Japan

Condition
Condition Perioperative patients
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We will compare the effect of 130 HES in volume expansion, hemodynamic parameters and peripheral perfusion with that of 70 HES and bicarbonated Ringer solution.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Increase of circulation blood volume at 10 minutes after the administration of 130 HES, 70HES or bicarbonated Ringer solution.
Key secondary outcomes Changes of blood pressure, heart rate, peripheral perfusion index and hemoglobin at 10 minutes after the administration of 130 HES, 70HES or bicarbonated Ringer solution.

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment No need to know

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Intravenous administration of 500 ml of 130 HES in 10 minutes
Interventions/Control_2 Intravenous administration of 500 ml of 70 HES in 10 minutes
Interventions/Control_3 Intravenous administration of 500 ml of bicarbonated Ringer solution in 10 minutes
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with 1-2 of ASA physical status in elective surgery.
Key exclusion criteria Patients with cardiovascular disease, hemorrhage and/or dehydration.
Target sample size 120

Research contact person
Name of lead principal investigator Hiroaki Toyama
Organization Tohoku University hospital
Division name Department of Anesthesiology
Address 1-1 Seiryomachi, Aoba-ku, Sendai, Japan
TEL 022-717-7321
Email h-toyama@umin.ac.jp

Public contact
Name of contact person Hiroaki Toyama
Organization Tohoku University Hospital
Division name Department of Anesthesiology
Address 1-1 Seiryomachi, Aoba-ku, Sendai, Japan
TEL 022-717-7321
Homepage URL
Email h-toyama@umin.ac.jp

Sponsor
Institute Department of Anesthesiology, Tohoku University Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Department of Anesthesiology, Tohoku University Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor None
Name of secondary funder(s) None

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東北大学病院(宮城県)

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 13 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 10 Month 01 Day
Anticipated trial start date
2015 Year 11 Month 01 Day
Last follow-up date
2016 Year 02 Month 28 Day
Date of closure to data entry
2016 Year 02 Month 28 Day
Date trial data considered complete
2016 Year 02 Month 28 Day
Date analysis concluded
2016 Year 02 Month 28 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 10 Month 13 Day
Last modified on
2016 Year 06 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022159